The role of 99mtc-sestamibi scintimammography and colour doppler ultrasonography in the evaluation of breast lesions

Nuclear Medicine Communications

Volumn 22, Issue 11, 2001, Pages 1243-1248

  Koukouraki, S ^a   Koukourakis, M I ^a   Vagios, E ^a   Velidaki, A ^a   Tsiftsis, D ^a   Karkavitsas, N ^a  

^a UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

Author keywords

99mTc sestamibi; Breast lesions; Colour Doppler ultrasonography; Scintimammography

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; ASPIRATION CYTOLOGY; BREAST CANCER; BREAST LESION; COLOR ULTRASOUND FLOWMETRY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MEMBRANE POTENTIAL; SCINTIMAMMOGRAPHY; TUMOR VASCULARIZATION;

ADULT; AGED; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; HUMANS; MENOPAUSE; MIDDLE AGED; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M SESTAMIBI; ULTRASONOGRAPHY, DOPPLER, COLOR;

EID: 0034762637     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200111000-00012     Document Type: Review

References (27)

1. Buscombe JR, Cwikla JB, Thakrar DS, Hilson AJW. Scintigraphic imaging of breast cancer: A review. Nucl Med Commun 1997; 18: 698-709.
2. Sondik ES. Breast cancer trends. Incidence, mortality and survival. Cancer 1994; 74: 995-999.
3. Veronesi U. The state of the preoperative disgnosis of breast cancer today. J Nucl Med 1997; 41: 177-178.
4. Feig SA. Role and evaluation of mammography and other imaging methods for breast cancer detection, diagnosis, and staging. Semin Nucl Med 1999; 29: 3-15.
5. Hillner BE. Decision analysis: MIBI imaging of nonpalpable breast abnormalities. J Nucl Med 1997; 38: 1772-1778.
6. Piccolo S, Lastoria S, Muto P, Bazzicalupo L, Bartiromo A, Salvatore M. Scintimammography with 99mTc-MDP in the detection of primary breast cancer. J Nucl Med 1997; 41: 225-230.
7. Yutani K, Shiba E, Kusuoka H, et al. Comparison of FDG-PET with MIBI-SPECT in the detection of breast cancer and axillary lymph node metastasis. J Comput Assist Tomogr 2000; 24: 274-280.
8. Koukourakis M, Koukouraki S, Giatromanolaki A, Skarlatos J, Georgoulias V, Karkavitsas N. Non small cell lung cancer functional imaging: Increased hexakis-2-methoxy-isobutyl-isonitrile tumor clearance correlates with resistance to cytotoxic treatment. Clin Cancer Research 1997; 3: 749-754.
9. Delmon-Moingeon LI, Piwnica-Worms D, Van Den Abbeele AD, Holman BL, Davison A, Jones AG. Uptake of the cation hexakis (2-methoxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990; 50: 2198-2202.
10. Scopinaro F, Schillaci O, Scarpini M, et al. Technetium-99m: an indicator of breast cancer invasiveness. Eur J Nucl Med 1994; 21: 984-987.
11. Tohno E, Cosgrove D, Sloane J, Vagios E. Ultrasound diagnosis of breast diseases. Edinburgh: Churchill Livingstone, 1994.
12. Svane G, Potchen EJ, Sierra A, Azavedo E, et al. Screening mammography. Breast cancer diagnosis in asymptomatic women. St Louis: Mosby, 1993.
13. Cosgrove DO, Kedar RP, Vagios E, et al. Color Doppler in differential diagnosis of breast masses. Radiology 1993; 189: 99-104.
14. Madjar H, Prömpeler HJ, Saverbrei W, Wolfarth R, Pfleiderer A. Color doppler flow criteria of breast lesions. Ultrasound Med Biol 20: 849-858.
15. Kopans DB. The positive predictive value of mammography. Am J Roentgenol 1992; 158: 521-526.
16. Breast cancer screening outcomes in women ages 40-49: Clinical experience with service screening using modern mammography. Monogr Natl Cancer Inst 1997;: 99-104.
17. Melloul M, Paz A, Ohana G, et al. Double-phase 99mTc-sestamibi scintimammography and trans-scan in diagnosing breast cancer. J Nucl Med 1999; 40: 376-380.
18. Prats E, Aisa F, Abós MD, et al. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer. J Nucl Med 1999; 40: 296-301.
19. Khalkhali I, Iraniha S, Cutrone JA, Diggles LE, Klein SR. Scintimammography with Tc-99m sestamibi. Acta Med Austriaca 1997; 24: 246-249.
20. Palmedo H, Biersack HJ, Lastoria S, et al. Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial. Eur J Nucl Med 1998; 25: 375-385.
21. Tolmos J, Cutrone JA, Wang B, et al. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography. J Natl Cancer Inst 1998; 90: 846-849.
22. Cwikla JB, Buscombe JR, Kelleher SM, et al. Comparison of accuracy of scintimammography and X-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy. Clin Radiol 1998; 53: 274-280.
23. Chen SL, Yin YQ, Chen JX, et al. The usefulness of technetium-99m-MIBI scintimammography in diagnosis of breast cancer: using surgical histopathologic diagnosis as the gold standard. Anticancer Res 1997; 17: 1695-1698.
24. Lumachi F, Marzola MC, Zucchetta P, et al. Breast cancer detection with 99m-Tc-sestamibi scintigraphy, mammography, and fine-needle aspiration cytology: comparative study in 64 surgically treated patients. Ann Surg Oncol 1999; 6: 568-571.
25. Klaus AJ, Klingensmith WC, Parker SH, Stavros AT, Sutherland JD, Aldrete KD. Comparative value of 99mTc-sestamibi scintimammography and sonography in the diagnostic workup of breast masses. Am J Roentgenol 2000; 174: 1779-1783.
26. Mekhmandarov S, Sandbank J, Cohen M, Lelcuk S, Lubin E. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions. J Nucl Med 1998; 39: 86-91.
27. Buscombe JR, Cwikla JB, Thakrar DS, Hilson AJ. Uptake of Tc-99m MIBI related to tumour size and type. Anticancer Res 1997; 17: 1693-1694.